KURA ONCOLOGY, INC. (KURA) Return on equity 2023–2025
KURA ONCOLOGY, INC. (KURA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-160.0%FY2025 · since FY2023: -38.4% → -160.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -160.0% | -118.0 pp |
| FY2024 | -42.1% | -3.6 pp |
| FY2023 | -38.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice